top of page
Home
Who we are
What we offer
Clients
Technologies
Mucosis vaccine technology
News
Contact
More
Use tab to navigate through the menu items.
Virtuvax News
Mucosis Announces Re-issue of Major Patent by US Patent Office USPTO
Patented technology applied in SynGEM, a needle-free nasal spray vaccine against respiratory syncytial virus * Re-Issuance of U.S. Patent...
bottom of page